This study evaluated the expression of the IL-17-induced increased expression of PD1/PDL1 among ER-negative and triple negative cases of breast cancer (TNBC), and identified that PD1/PDL1 increased with the decreased expression of ER. The gene discussed is IL17A; the disease is breast cancer.